Nefrosol

Sodium hydrogen carbonate, the active ingredient in Nefrosol, is a IV electrolyte solution presented as a solution for injection for intravenous use. It provides electrolyte replacement and helps maintain fluid balance in patients requiring intravenous therapy.

GNH USA supplies Nefrosol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nefrosol is employed in clinical situations that require intravenous electrolyte and fluid management. - Diluent for intravenous medications: Provides a compatible carrier solution for reconstituting and diluting injectable drugs. - Electrolyte replacement therapy: Restores sodium, chloride, calcium, and magnesium levels in patients with deficits. - Fluid resuscitation in dehydration: Supplies necessary volume and electrolytes to support circulatory volume. - Correction of electrolyte imbalances: Adjusts specific ion concentrations such as hyponatremia, hypocalcemia, or hypomagnesemia.

Nefrosol may be associated with adverse reactions following intravenous administration.

Common Side Effects: - Injection site pain: Mild discomfort at the infusion site. - Mild hypernatremia: Slight increase in serum sodium. - Mild hyperchloremia: Slight elevation of chloride levels. - Transient metabolic alkalosis: Temporary rise in blood pH. - Mild hypercalcemia: Small increase in calcium concentration. - Mild hypermagnesemia: Small increase in magnesium concentration.

Serious or Rare Side Effects: - Severe hypernatremia: Marked elevation of serum sodium requiring urgent intervention. - Severe metabolic alkalosis: Significant pH shift that may affect cardiovascular function. - Anaphylactic reaction: Acute hypersensitivity requiring emergency treatment. - Circulatory overload: Fluid accumulation leading to pulmonary edema.

When using Nefrosol, clinicians should observe several safety measures. - Assess electrolyte status before administration: Check serum sodium, chloride, calcium, and magnesium levels. - Monitor fluid balance: Track input/output and watch for signs of overload. - Adjust infusion rate in renal impairment: Reduce volume to avoid accumulation. - Avoid concurrent hypertonic solutions: Prevent excessive electrolyte load. - Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Nefrosol can interact with other intravenous therapies and medications.

Major Interactions (Avoid): - Concurrent use of hypertonic saline solutions: Increases risk of severe hypernatremia. - Co‑administration with calcium‑containing medications: May cause calcium overload. - Use with potassium‑sparing diuretics: Can exacerbate electrolyte imbalance.

Moderate Interactions (Monitor Closely): - Concurrent IV antibiotics with nephrotoxic potential: Requires renal function monitoring. - Simultaneous infusion of blood products: Watch for electrolyte shifts.